Nevertheless, the detection of isolated hippocampal atrophy in a subset of individuals points to the potential presence of co-pathologies such as amyloid-β or tau deposition, which may be active even in prodromal or early clinical stages. The gene discussed is MAPT; the disease is hippocampal atrophy.